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Introduction
Myotonic dystrophy (DM) types 1 and 2 are adult-onset, autosomal dominant, progressive multisystem disorders (Harper, 2001 ). DM1 and DM2 are clinically similar disorders with patients developing muscle wasting and myotonia, cardiac arrhythmias, iridescent cataracts, and central nervous system (CNS) abnormalities. Both DM1 and DM2 result from microsatellite repeat expansions in functionally distinct genes. DM1 is caused by a CTG expansion in the 3′ UTR of the dystrophia myotonica protein kinase (DMPK) gene and DM2 from an intronic CCTG expansion in the CCHC-type zinc finger, nucleic acid binding protein (CNBP) gene (Brook et al., 1992; Mahadevan et al., 1992; Fu et al., 1992; Liquori et al., 2001 ).
There is substantial support that DM1 CUG and DM2 CCUG expansion transcripts accumulate in RNA foci and disrupt alternative splicing factors, including the MBNL and CUG-BP-and ETR-3-like factors (CELF) proteins. Mouse models that demonstrate missplicing and /or loss of MBNL proteins reproduce many of the systemic and CNS splicing abnormalities (GomesPereira et al., 2007; Du et al., 2010; Charizanis et al., 2012; Suenaga et al., 2012; HernandezHernandez et al., 2013) . The sequestration of splicing factors by repeat expansion RNA transcripts not only provides for a compelling model of disease pathogenesis but also a potential therapeutic approach to DM based on upregulation of members of the MBNL family (Chamberlain and Ranum, 2012) .
Patients with either type of DM have debilitating neurological dysfunction including cognitive deficits (Harper, 2001 ). The cognitive deficits in DM patients include visual-spatial abnormalities, attention deficits, and impaired executive functioning (Rubinsztein et al., A C C E P T E D M A N U S C R I P T 4 1997; Meola et al., 2003; Modoni et al., 2004; Minnerop et al., 2011) . While DM1 patients are more likely to exhibit greater deficits than DM2 patients, the latter can have similar cognitive impairments (van Spaendonck et al., 1995; Meola et al., 1999; Meola et al., 2003; Gaul et al., 2006) . Anatomical and diffusion tensor imaging (DTI) documents widespread changes in the cerebral cortical white matter in DM1 and DM2 patients including in the corpus callosum (Fukuda et al., 2005; Ota et al., 2006; Wozniak et al., 2011; Minnerop et al., 2011; Franc et al., 2012) . Gray matter cell loss has also been reported, although less so in DM2 than DM1 patients (Ono et al., 1996; Kassubek et al., 2003; Antonini et al., 2004; Minnerop et al., 2011) . Furthermore, resting state fMRI studies in DM1 patients report changes in resting state connectivity (Serra et al., 2014; Serra et al., 2016) . These findings suggest that cerebral cortical circuits are altered in DM, particularly white matter tracts (Minnerop et al., 2011) .
The abnormalities in white matter integrity, loss of grey matter, and changes in functional connectivity are hypothesized to contribute to the CNS deficits in DM patients (Antonini et al., 2004; Wozniak et al., 2011; Minnerop et al., 2011; Franc et al., 2012) . However, little is known whether DM mouse models have comparable alterations in the cerebral cortical circuitry. To begin to address this issue, we developed a flavoprotein-based optical imaging assay of the effects of intracortical stimulation to map both local response as well as the response to activation of the corpus callosum (Shibuki et al., 2003; Reinert et al., 2004; Reinert et al., 2007) .
Flavoprotein autofluorescence is an activity-dependent signal based on changes in neuronal oxidation metabolism (Chance, 1991; Shibuki et al., 2003; Reinert et al., 2004; Reinert et al., 2011) . The flavoprotein signal reflects the underlying neuronal responses as assessed by field potentials or single unit activity and is therefore, a highly useful mapping signal (Shibuki et al., A C C E P T E D M A N U S C R I P T 5 2003; Coutinho et al., 2004; Husson et al., 2007; Wang et al., 2011; Cramer et al., 2013) .
Flavoprotein imaging, like intrinsic optical imaging (Lieke et al., 1989) , allows for a wide fieldof-view of neuronal activity across a large area of the brain (Cramer et al., 2015; Ma et al., 2016; Kozberg et al., 2016) . Therefore, this type of mesoscopic imaging provides an important tool to evaluate normal and abnormal response patterns and complements the cellular resolution, but more limited field-of-view, of two-photon imaging.
Next, we used this assay to investigate two mouse models related to DM. The first model is a Mbnl2 knockout (Mbnl2 (ΔE2/ΔE2) ) that develops many of the features of DM including deficits in synaptic transmission and plasticity (Charizanis et al., 2012) . Importantly, MBNL2 is the principal splicing factor disrupted in the CNS, and Mbnl2 KO mice do not develop muscle deficits. The second model involves two lines of transgenic mice that overexpress human MBNL1 (MBNL1-OE) in the CNS that were developed to test the therapeutic possibility of reversing the effect of sequestration of MBNL proteins by microsatellite expansions (Chamberlain and Ranum, 2012) .
Materials and Methods

Transgenic mice
To establish the normal responses to intracortical stimulation, male FVB mice, ages 4-8 months (Charles River Laboratories, Wilmington) were used. As described in the original publication (Chamberlain and Ranum, 2012) , L14686 mice overexpressing a 40k Da isoform of human MBNL1 were generated on the FVB background using the β-actin promotor. In addition to the previously published L14686 line (Chamberlain and Ranum, 2012) we generated and examined a A C C E P T E D M A N U S C R I P T 6 second independent transgenic mouse line (L15132) that overexpresses the same 40 kDa MBNL1 isoform in the CNS. This line, which constitutively overexpresses MBNL1, was generated from a construct expressing the same N-terminal FLAG-tagged humanized version of MBNL1 in which a floxed stop cassette had been removed by crosses with the Ella-Cre transgenic line (JAX Lab # 003314). This recombination event had been stably transmitted to the F2 progeny. The resulting singly transgenic MBNL1 positive progeny constitutively express the FLAG-tagged MBNL1 from early embryogenesis. The expression level of MBNL1 in this newly developed line (L15132) and that of the L14686 line was confirmed by immunoblot analyses. MBNL1 overexpression in both lines is generally well tolerated and has been previously described in detail for the L14686 line (Chamberlain and Ranum, 2012) . The generation and characterization of the Mbnl2 KO mice was previously described (Charizanis et al., 2012) , and used a homologous recombination strategy in which Mbnl2 exon 2 was deleted, as this exon encodes the initiation codon for the full length MBNL2 protein (Kanadia et al., 2003) .
The resultant Mbnl2
(ΔE2/ΔE2) mice (referred to as Mbnl2 KO mice) were on a C57Bl/6 background.
Animal preparation
All animal procedures were approved by and conducted in conformity with the Institutional Animal Care and Use Committee of the University of Minnesota and the University of Florida and in accordance with the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) . For physiological studies in the normal or the DM-related mice, the animals were anesthetized by an initial intramuscular injection of 2.0 mg/kg acepromazine followed by an intraperitoneal injection of 1.2 mg/kg urethane and
supplemented with 0.3 mg/kg urethane as needed. The electrocardiogram and response to toe pinch were monitored to assess the depth of anesthesia. The mice were placed in a stereotaxic frame, mechanically ventilated and body temperature feedback-regulated. A large craniotomy was performed bilaterally over the cerebral cortex that included the motor cortical areas, and the dura carefully removed. A watertight dental acrylic chamber was created around the exposed cortex and was filled and frequently rinsed with warmed (37°C) Ringer's solution gassed with 95% O 2 /5% CO 2 .
Optical imaging
Images were acquired with a high-speed, cooled charged-coupled device (CCD) macroscope (Nikon AZ-100) with a 512X512 chip using a 2X objective. Images were binned at 256X256 pixels, resulting in a pixel resolution of ~28 X 28 µm (MetaMorph, Sunnyvale, CA). The camera was focused 200-300 µm below the cerebral cortical surface. Flavoprotein autofluorescence imaging used a band-pass excitation filter (455 ± 35 nm), an extended reflectance dichroic mirror (500 nm), and a > 515 nm long-pass emission filter (Reinert et al., 2004) . Responses are reported as ΔF/F 0 (%), with F 0 being the average of the first 20 prestimulation frames of an image series consisting of 80 sequential frames (200 ms per frame) for single pulse stimulations or 425 sequential frames (200 ms per frame) for train stimulation (see below).
Direct cortical stimulation
Direct electrical stimulation of the motor cortex was delivered by a parylene coated microelectrode (2-5 M) placed ~300-400 m below the surface of the motor cortex (~1.5 mm
rostral and lateral to bregma). In several preliminary experiments, these coordinates were found to evoke strong and consistent ipsilateral and contralateral optical responses. Three stimulation protocols were used. The first protocol (used in Figures 1, 2 , 5, 6, and 8) consisted of a one second train of 10 pulses (200 µA, 100 µs) at 10 Hz to establish the ipsilateral and contralateral response patterns in both wild-type mice and DM models. Typically, this stimulus train was repeated 2-6 times at an interval of 5 min to establish the baseline responses in wild-type and disease models. In animals with a pharmacological manipulation, the baseline stimulation was followed by up to 4 repetitions after application of a drug. The second protocol (used in Figure   3 ) was designed to map the optical responses with field potential recordings and consisted of a 
Analysis of the optical responses
To quantify changes in the flavoprotein autofluorescence responses to direct electrical stimulation, regions of interest (ROIs) were defined visually. The ROIs were circular (0.8 mm diameter) and were placed over the center of the ipsilateral and contralateral regions of increased fluorescence for the 10 Hz train stimulation protocols (see Fig. 1 ). The train stimulation evoked
an initial increase in fluorescence followed by a decrease in fluorescence (Shibuki et al., 2003; Reinert et al., 2004; Coutinho et al., 2004; Cramer et al., 2015) . The former results from the oxidation of mitochondrial flavoproteins in postsynaptic neurons and is tightly coupled to stimulation strength (Shibuki et al., 2003; Reinert et al., 2004; Brennan et al., 2006; Reinert et al., 2007) . All analyses of the responses to the train stimulation were based on the increase in fluorescence. To quantify the amplitude of the response to train stimulation in the selected ROI, we determined the average ΔF/F 0 for the five frames centered on the peak increase in fluorescence. The single pulse stimulation evoked a more complex response consisting of a central region with an increase in fluorescence surrounded by a region of decreased fluorescence.
Therefore, the analyses of the responses included placing the circular ROIs over the center of the ipsilateral and contralateral regions of increased fluorescence, and in the surrounding regions of decreased fluorescence (see Fig. 4A ). The placement of the ROIs were chosen based on visual observation to obtain the maximal (center) or minimal (surround) flavoprotein response to stimulation. Therefore, between animals, the ROI placement will differ depending on the location of the maximal and minimum responses. However, within the same animal, ROI placement remained constant throughout baseline and drug application. The response amplitude was measured at two time points: an early time point (early phase) that captured the peak decrease in fluorescence in the surround ROI; and a later time point (late phase) that captured the peak increase in fluorescence in the center ROI (see Fig. 4B and C). At both time points, the average ΔF/F 0 over 2 frames (0.4 s) was determined.
Field potential recordings and analysis
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Field potentials were recorded at a depth of 300 µm in the contralateral cortex to intracortical stimulation (16 single pulses with a 1 s interval) using glass microelectrodes filled with 2 M NaCl (2-5 MΩ), digitized at 25 KHz and the responses to the 16 stimuli averaged. The field potentials were recorded at 0.5 mm intervals, lateral to medial, across the extent of the evoked flavoprotein response (see Fig. 3 ). The amplitude of the initial large negativity was determined and used as a measure of the post-synaptic excitatory response (Hoffmeyer et al., 2007) .
Drugs and administration
Various drugs were applied in normal Ringer's solution to the exposed cerebral surface, (100 M TTX, 15-25 psi for 1-2 s) were delivered through a glass microelectrode connected to a pico-injection system (PLI-100; Medical Systems). The insertion point of the microelectrode was -0.6 mm anteroposterior, 0.5 mm medial lateral relative to bregma, and advanced a total distance of 3.0 mm at an angle of 10° off midline, 38° relative to the horizon. This allowed for targeted injection of TTX into the corpus callosum centered between the evoked ipsilateral and contralateral flavoprotein response. All drugs were purchased from Tocris Bioscience (Ellisville, MO).
Statistical analysis
The statistical analysis was performed using SAS software (SAS Institute Cary, NC). The effects of the different drugs or genotype on the optical responses were statistically evaluated by the appropriate ANOVA (repeated measures within or between subject designs, p < 0.05)
followed by post-hoc testing using the Bonferroni method to control for multiple comparisons.
In all experiments, the amplitudes of the ipsilateral and contralateral responses differed.
Therefore, analyses focused on testing for differences in the responses evoked on the ipsilateral and contralateral sides separately. In experiments comparing the optical and field potential responses, the amplitude of the optical response was regressed against the initial negativity of the field potential at each recording location, and the coefficient of determination (R 2 ) and F-statistic was determined. Throughout the text and figures, values are reported as mean + standard deviation (SD) and "n" refers to the number of animals used in an experiment.
Results
Flavoprotein responses to intracortical stimulation
We first characterized the flavoprotein responses evoked by direct electrical stimulation of the primary motor cortex in FVB wild-type mice using 10 Hz stimulation for 1 s. We selected the primary motor cortex to study based on a series of preliminary experiments that showed robust and consistent ipsilateral and contralateral responses to intracortical stimulation. Also, the corpus callosum in the mouse is well-developed in this region of the frontal lobes (Mitchell and Macklis, 2005; Chovsepian et al., 2017) , and changes in the corpus callosum in the frontal lobes have been reported in DM patients (Fukuda et al., 2005; Ota et al., 2006; Wozniak et al. ,
2011; Minnerop et al., 2011; Franc et al., 2012) . Train stimulation evoked a strong increase in flavoprotein autofluorescence in the ipsilateral hemisphere centered on the stimulating electrode, and a concurrent increase in the contralateral hemisphere in the same homotopic area (Fig. 1A) , consistent with transmission through the corpus callosum. Following the initial increase in flavoprotein autofluorescence, there was a prolonged decrease in autofluorescence (Fig. 1B) , similar to that previously reported for the cerebellar and cerebral cortex (Shibuki et al., 2003; Reinert et al., 2004; Brennan et al., 2006; Cramer et al., 2015) . The response amplitude was 2.38 ± 0.87% in the ipsilateral hemisphere, but was significantly smaller in the contralateral side at 1.48 ± 0.58% ( Arrows denote times at which images from A were taken. C. Quantification of the peak flavoprotein autofluorescence response on the ipsilateral (red) and contralateral (blue)
hemisphere.
Next, we addressed the synaptic circuitry involved in the optical responses. As both intracortical and transcallosal projections terminate in glutamatergic synapses and primarily activate postsynaptic AMPA and NMDA receptors (Keller, 1993; Kumar and Huguenard, 2001) , we tested the contributions of these glutamate receptors to the autofluorescence responses. Co-application of the AMPA receptor antagonist DNQX (100 µM), and the NMDA receptor antagonist APV (250 µM), onto the exposed cortex greatly suppressed the flavoprotein response in both the ipsilateral (F(3,6)=24.89, p<0.001, Bonferroni, p<0.01) and contralateral (F(3,6)=61.84, p<0.001, n=4, Bonferroni, p<0.01) hemispheres ( Fig. 2A and B) . Local field potentials (LFPs)
were also greatly reduced, with only a small negative deflection remaining that most likely represents the afferent fiber volley in the corpus callosum fibers. Interestingly, DNQX/APV did not completely block either the ipsilateral or contralateral optical responses suggesting that other receptor types may be involved in the synaptic activation and that some of the ipsilateral activation was due to the direct effects of stimulation. Another possible explanation is that there was only a partial block of AMPA/NMDA receptors, however, the concentration of antagonists used here have been shown to obtain a high level of glutamate receptor block (Shlosberg et al., 2006; Haley et al., 2016) . Washout of the drugs resulted in a significant increase in the response amplitude (Bonferroni, p<0.01 for both hemispheres). Topical application of tetrodotoxin (TTX,
10 µM), completely blocked the autofluorescence in both hemispheres (Bonferroni, p<0.01) and abolished the remaining fiber volley. These findings show that the optical responses in both hemispheres are activity-dependent, with a large contribution from synaptic activation of ionotropic glutamate receptors. in both hemispheres shows that the effect of the TTX was restricted to the corpus callosum at the midline and that the contralateral response was mediated by the corpus callosum.
Changes in blood flow do not account for the flavoprotein responses
We next tested whether changes in blood flow contribute to the flavoprotein autofluorescence responses. The two major pathways mediating increased blood flow in response to neural activity are the neuronal nitric oxide synthase (nNOS) pathway that produces nitric oxide (NO)
in response to neural activation and the cyclooxygenase (COX) pathway that produces multiple signaling molecules including prostaglandins in response to astrocyte activation (Hoffmeyer et al., 2007; Kitaura et al., 2007; Attwell et al., 2010) . Blocking nitric oxide synthase with L-NAME (1 mM) had no effect on the evoked optical responses in either hemisphere (ipsilateral: 1.50 ± 0.52% and 1.60 ± 0.53%, baseline and L-NAME, respectively, F(1,3)=4.34, n=4, p =0.13; contralateral: 1.11 ± 0.37% and 1.16 ± 0.23%, F(1,3)=0.25, p=0.65). Similarly, blocking cyclooxygenase with indomethacin (100 µM) had no effect (ipsilateral: 2.14 ± 0.86% and 2.06 ± 0.82%, baseline and indomethacin, respectively, F(1,3)=0.14, n=4, p=0.73; contralateral: 1.48 ± 0.50% and 1.32 ± 0.36%, F(1,3)=2.99, p=0.18). These concentrations have been shown to block vasodilatory responses to electrical stimulation in both the cerebral and cerebellar cortex (Ellis et al., 1990; Yang and Iadecola, 1998; Shibuki et al., 2003; Toth et al., 2011) . Taken together, these data suggest the ipsilateral and contralateral flavoprotein responses are not due to vasodilation, but are neuronal in origin.
Mapping of local field potentials and flavoprotein signals
To determine the relationship between the evoked optical and neuronal responses, electrophysiological mapping experiments were performed. After recording the optical responses, extracellular field potentials were obtained at several lateral-medial locations across the contralateral optical response. As shown for an example mapping study (Fig. 3 A-C) , the larger amplitude field potentials (#4-6) were recorded near the center of the optical response and the smaller amplitude field potentials further from the response center. To quantify this relationship, the response amplitude (ΔF/F 0 ) at the site of the field potential recording was regressed against the peak of the initial negativity (see Materials and Methods.) . This initial
negativity reflects the excitatory synaptic potential (Hoffmeyer et al., 2007) . The coefficient of variation (R 2 ) for the example experiment was 0.96 (blue symbols and regression line in Fig. 3D , F-statistic, p<0.001), confirming a robust linear relation between the optical and field potential recordings. A significant linear relation was observed in all four animals (Fig. 3D) . Therefore, the change in flavoprotein fluorescence is strongly coupled to the underlying neuronal activity, specifically the evoked excitatory post-synaptic response. 
Flavoprotein autofluorescence detects both excitation and inhibition
Both local intracortical and transcallosal projections can also activate inhibitory interneurons in the cortex. Much of this inhibition is GABAergic and generates a center-surround pattern of excitation-inhibition, respectively (Derdikman et al., 2003; Helmstaedter et al., 2009; Fino and Yuste, 2011) . Typically, defining this center-surround organization has relied on electrophysiological mapping. Because flavoprotein imaging monitors both increases and decreases in neuronal activity in the cerebellar cortex (Gao et al., 2006; Reinert et al., 2007; Reinert et al., 2011) , we tested whether the flavoprotein response could detect the inhibitory surround organization in the cerebral cortex. However, train stimulation or single pulse stimulation with a 1 s interval evoked only an increase in fluorescence. We reasoned that the large and long lasting increase in fluorescence at these stimulation parameters might obscure a smaller decrease in fluorescence that reflects synaptic inhibition. Therefore, to better distinguish between excitation and inhibition, stimulation with a single pulse with a 20 s interval was used.
In both the ipsilateral and contralateral hemispheres, the single pulse stimulation protocol evoked a central region of increased fluorescence surrounded by a fluorescence decrease (Fig. 4) . The
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A C C E P T E D M A N U S C R I P T 19 surrounding decrease in fluorescence had a latency of about 0.4-0.6 s, peaked about 1 s, and evolved into a fluorescence increase (Fig. 4A, B and C) . Because of the bimodal temporal profile of the optical responses, we quantified both an early and late phase to capture the fluorescence decrease of the surround and the fluorescence increase of the center (Fig. 4B and C) . In FVB control mice, the early phase ipsilateral and contralateral responses in the surround region exhibited a decrease in ΔF/F 0 relative to baseline and differed from the fluorescence change in the center (ipsilateral: F(3,9)=35.14, n=4, p<0.0001; contralateral: F(3,9)=37.44, p<0.0001, Bonferroni, p<0.01 for both sides). During the late phase, the surround regions evolved into a fluorescence increase in both hemispheres (Fig. 4E ). We hypothesized and tested whether the surround decrease in fluorescence was due to synaptic inhibition and mediated by GABA A receptors. Addition of the GABA A antagonist, Gabazine (1 µM), to the optical recording chamber completely blocked the surround decrease in fluorescence (Fig. 4A ). In addition, Gabazine expanded the area of increased fluorescence and decreased the latency (Fig. 4A , B, and C). The population data ( Fig. 4D and E) show that the early phase surround decreases in fluorescence were abolished and converted into fluorescence increases in both hemispheres (ipsilateral: F(3,9)=35.14, n=4, p<0.001; contralateral: F(3,9)=37.44, p<0.001, Bonferroni, p<0.01). Similarly, during the early phase the center fluorescence increased in both hemispheres (Bonferroni, p<0.01).
A C C E P T E D
During the late phase, Gabazine increased the surround response in both hemispheres and the amplitude of the central response in the contralateral hemisphere (ipsilateral F(3,9)=9.13, p=0.0043
and contralateral F(3,9)=10.12, p=0.0031, Bonferroni, p<0.01). However, the amplitude of the ipsilateral center response during the later phase did not change (Bonferroni, p=0.083). These findings are consistent with single pulse stimulation generating GABA synaptic inhibition both around the site of stimulation and the surrounding area.
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Flavoprotein imaging in Mbnl2 KO mice
We used the intracortical stimulation assay to assess the cerebral cortical circuitry in the Mbnl2 KO mouse model of DM developed by Swanson and colleagues (Charizanis et al., 2012) . These experiments used 8 Mbnl2 KO and 7 littermate C57Bl/6 wild-type mice. The peak amplitude of the response to 10 Hz intracortical stimulation in Mbnl2 KO mice did not differ from controls ( Fig.   5A and B), both ipsilaterally (F(1,13)=0.44, p=0.5174) and contralaterally (F(1,13)=0.11, p=0.7463). However, two aspects of the response to 10 Hz stimulation differed from wild-type mice. First, the response duration was increased in Mbnl2 KO mice. As shown in the example images and time course plots ( Fig. 5A and C 
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In Mbnl2 KO mice, 10 Hz stimulation also evoked a larger area of activation. As shown in example experiments (Fig. 6A ) in Mbnl2 KO mice intracortical resulted in larger regions of activation than in wild-type animals in which the fluorescence increase was typically confined to a region surrounding the stimulation site and the mirror region in the contralateral hemisphere. In
Mbnl2 KO mice, the activation typically included a posterior region bilaterally along the midline that was most evident at longer latencies (Fig. 6A ). These regions in the parietal lobes correspond approximately to the retrosplenial cortex (Vogt and Peters, 1981; Paxinos, 2003) . To quantify these additional sites of activation, rectangular ROIs (Ip-Ex and Co-Ex, 0.8 x 1.4 mm) were placed bilaterally centered 0.7 mm lateral and 2.2 mm posterior from bregma, and the average ΔF/F 0 from 5-7 s after stimulation onset calculated (Fig. 6A ). Mbnl2 KO mice exhibited increased fluorescence in these regions bilaterally compared to wild-type animals (ipsilateral: F(1,13)=5.37, p=0.037; contralateral: F(1,13)=6.18 , p=0.027, Fig. 6B ). As observed for response duration in Mbnl2 KO mice, there was increased variability as shown in the frequency distribution of the fluorescence changes in the extra regions ( Fig. 6C and 6D ). Therefore, 10 Hz intracortical simulation in Mbnl2 KO mice increases response duration and activates additional cortical areas.
While statistically significant, these two aspects of the responses to 10 Hz stimulation also demonstrate increased variability. We also evaluated the responses to single pulse stimulation in Mbnl2 KO and C57Bl/6 wild-type mice. As shown for a representative Mbnl2 KO mouse, both an increased center response and a reduced inhibitory-like surround to single pulse stimulation was observed (Fig. 7A) . In the overall
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A C C E P T E D M A N U S C R I P T 27
Flavoprotein imaging in Mbnl1-OE mice
A major theory of pathogenesis in DM is that the abnormal RNA transcripts sequester splicing factors, particularly MBNL proteins (Cardani et al., 2006; Lee and Cooper, 2009; Du et al., 2010; Charizanis et al., 2012) . Conversely, restoring splicing factors has been proposed as a therapeutic approach to mitigate the process. Mice engineered to overexpress human MBNL1
(MBNL1-OE) were shown to reverse the skeletal muscle abnormalities (Chamberlain and Ranum, 2012) . However, whether MBNL1 overexpression had effects on the central nervous system was not evaluated. Therefore, we next examined the optical responses to intracortical stimulation to determine if overexpression of MBNL1 affects cerebral cortical circuitry.
We tested two MBNL1-OE lines: L14686 (n=8 FVB wild-type and OE, each); and L15132 (n=6 
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Finally, we tested the response to single pulse stimulation in both MBNL1-OE lines: L14686 (n=6 FVB wild-type, and n=5 OE); and L15132 (n=7 FVB wild-type and OE, each). The inhibitorylike surround observed above in FVB mice was markedly reduced in MBNL1-OE mice, as shown in the example experiment (Figs. 9A and B) . The surround decrease in fluorescence was much less evident in both hemispheres from the L14686 line compared to control. Consistent with the decrease in surround inhibition, there was a significant increase in fluorescence in the center of the response in both hemispheres of the MBNL1-OE mouse. The population results show that the inhibitory-like surround during the early phase was significantly different from the controls in L14686 (ipsilateral: F(2, 9)=27.92, p < 0.0001, contralateral: F(2, 9)=138.65, p < 0.0001, Bonferonni, p<0.01), and the contralateral surround in L15132 (contralateral: F(2, 12)=74.69, p<0.0001, Bonferonni, p<0.05). Additionally, the response in all ROIs were greater in the late phase in both hemispheres for both L14686 (ipsilateral: F(2,9)=97.28, p<0.0001, contralateral:
F(2,9)=24.53, p=0002, Bonferonni, p<0.01 for both sides) and in L1532 (ipsilateral:
F(2,12)=147.7, p<0.0001, contralateral F(2,12)=53.8, p<0.0001, Bonferonni, p<0.01 for both sides). Therefore, the normal GABAergic inhibition evoked by intracortical and corpus callosum stimulation was reduced in MBNL1-OE mice. Same as C except for L15132. Both lines showed a larger fluorescence response in the surrounding ROIs compared to the WT mice.
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Discussion
Major findings
In this study, we demonstrated that flavoprotein imaging can be used to map neuronal activity in response to intracortical stimulation of the mouse cerebral cortex. The mesoscopic capabilities of flavoprotein imaging (Cramer et al., 2015; Ma et al., 2016; Kozberg et al., 2016) Overexpression of MBNL1 revealed a weaker contralateral response, and a lack of inhibitorylike surround response. Thus, flavoprotein imaging reveals several changes in cerebral cortical circuits in these two DM-related mouse models.
Neuronal basis for flavoprotein response
Stimulation of the motor cortex at 10 Hz resulted in a strong ipsilateral response that consisted of a central region of increased fluorescence, consistent with previous reports in the mouse cerebral cortex (Hishida et al., 2011) . TTX abolished the contralateral response, demonstrating that the response was primarily neuronal and that action potentials were extensively involved in activating both the neighboring ipsilateral cortex and contralateral hemisphere. A large fraction
of the fluorescence increase was due to postsynaptic activation of neurons as blocking ionotropic glutamate receptors greatly reduced both the ipsilateral and contralateral responses. However, it is likely that mechanisms other than ionotropic glutamatergic synaptic transmission contribute to the fluorescence increase, as only ~53 ± 9 % was blocked ipsilaterally and ~74 ± 7 % blocked contralaterally by APV and DNQX. While the ipsilateral response is likely to involve direct activation of neurons that would not be blocked by ionotropic glutamatergic antagonists, direct electrical activation cannot account for the remaining 25% not blocked in the contralateral hemisphere. Several other classes of excitatory synaptic transmission or post-synaptic receptors may contribute, including metabotropic glutamate receptor types 1 and 5, as both are involved in the cerebral cortical circuitry (Ferraguti and Shigemoto, 2006; Alexander and Godwin, 2006) .
Another potential contributor to the flavoprotein signal is changes in blood flow and/or blood oxygenation. The two major mediators of increasing cerebral blood flow, the nNOS and cyclooxygenase (COX) pathways respectively, account for ~85% of the increase in blood flow that accompanies neuronal activation (Hoffmeyer et al., 2007; Kitaura et al., 2007; Attwell et al., 2010) . Blocking either of these two pathways had no significant effect on the optical responses,
showing that the vast majority of the changes in flavoprotein fluorescence was not mediated by changes in blood flow. The lack of a significant blood flow contribution to the flavoprotein signal is consistent with previous findings in several species in both the cerebellum and cerebral cortex of anesthetized animals (Shibuki et al., 2003; Reinert et al., 2004; Husson et al., 2007; Reinert et al., 2007) .
Single pulse stimulation evoked a more complex pattern characterized by a central region of increased fluorescence surrounded by decreased fluorescence. The latter region is consistent with surround inhibition, as blocking GABA A receptors converted the fluorescence decrease into an increase. While surround inhibition is considered a fundamental feature of the neocortical architecture and shapes information processing (Krimer and Goldman-Rakic, 2001; Kremkow et al., 2010; Isaacson and Scanziani, 2011) , most studies of surround inhibition used electrophysiological recordings that have some limitations in revealing the spatial characteristics.
An advantage of flavoprotein imaging is the ability to provide a relatively high resolution spatial map. Previous work showed that patches of decreased fluorescence in the cerebellar cortex evoked by parallel fiber stimulation are due to GABA A inhibition (Gao et al., 2006) . To our knowledge, this is the first report using flavoprotein imaging to monitor both excitation and inhibition in the cerebral cortex, further extending the utility of this technique.
Involvement of the corpus callosum
The corpus callosum is the largest commissural tract in the human brain and connects the cerebral hemispheres (Paul et al., 2007; Edwards et al., 2014; Fenlon and Richards, 2015) .
Originating primarily from neurons in the cortical layers II/III and layer V of the neocortex, callosal axons project to equivalent locations in the contralateral cortex (Wahl et al., 2007; Wahl et al., 2009 ). An essential pathway for transfer of intrahemispheric information, callosal axons are excitatory and synapse both on excitatory neurons in the contralateral cortex and also on inhibitory interneurons. These precise homotopic patterns of connections play important roles in coordination of cortical functions, including motor, sensory and cognitive processes (Paul et al., 2007; Edwards et al., 2014) . In our results, the properties of the activated region in the
contralateral hemisphere were similar to the ipsilateral response following either 10 Hz train or single pulse stimulation in naïve wild-type mice. While these properties are consistent with the contralateral increase in fluorescence being mediated by the corpus callosum, a more definitive test was that small volumes (~ 30-35 nL) of TTX injected into the corpus callosum at the midline abolished the contralateral response, yet the ipsilateral response remained unchanged.
There has been a long standing debate as whether the primary function of the corpus callosum is to excite or inhibit the opposite hemisphere (Cook, 1984; Yazgan et al., 1995; Bloom and Hynd, 2005) . While the present study was not designed to answer this question, the results do show that the level of excitation or inhibition is likely dependent on the pattern of corpus callosum stimulation. Furthermore, altering the expression of MBNL splicing factor changes the balance of excitation and inhibition evoked by corpus callosum transmission.
Flavoprotein imaging in the Mbnl2 KO model of myotonic dystrophy
Both the ipsilateral and contralateral responses to intracortical stimulation were used to investigate mouse models relevant to DM pathogenesis. The Mbnl2 KO mouse model recapitulates many key disease features (Charizanis et al., 2012) . Several differences in the responses to intracortical stimulation were observed in this model. Longer duration responses and activation of additional cortical regions characterized 10 Hz stimulation in Mbnl2 KO mice.
The normal surround inhibition evoked by stimulation with a single pulse was absent in Mbnl2 KO mice and there was a concomitant increase in the excitatory component of the response.
These changes were present bilaterally and together imply increased cortical responsiveness to direct stimulation. This increased responsiveness is consistent with the augmented seizure
susceptibility observed in Mbnl2 KO mice (Charizanis et al., 2012) and in the DMSXL transgenic model of DM that expresses a human DMPK transgene with CTG expansion ranging from 1200-1700 in length (Gomes-Pereira et al., 2007) . There have been a small number of case reports showing comorbidity of epilepsy in DM1 (Worku, 2014; Kajal et al., 2017) and DM2 (Cagnetti et al., 2014; Giuliano et al., 2016) , however there has been no definitive link between increased seizure susceptibility and DM. It has also been reported that increased neurosecretion occurs in cell cultures expressing toxic CUG repeats (Hernandez-Hernandez et al., 2013) .
Together these observations support the hypothesis that DM has characteristics of an altered excitability disorder (Charizanis et al., 2012) , however, not necessarily producing a seizure disorder (Yayla et al., 2017) .
The engagement of additional cortical areas with intracortical stimulation, specifically the retrosplenial cortex, is intriguing in that the retrosplenial cortex is involved in several cognitive functions including navigation, episodic memory, imagination, and planning for the future (Vann et al., 2009) . Abnormal circuitry function and information processing in the retrosplenial cortex could contribute to abnormalities in these behaviors observed in DM patients. However, we add that to our knowledge, there are no reports of retrosplenial involvement in DM1 or DM2. Given this important caveat, the abnormal responses in Mbnl2 KO mice highlight that the changes in splicing factors associated with DM alter cerebral cortical functional connectivity.
The present in vivo results when taken together with previous results suggest complex changes in synaptic functioning in the Mbnl2 KO mice. Mbnl2 KO mice also exhibit decreased NMDAmediated receptor potentials and long-term potentiation in CA1 pyramid cells of the hippocampus Charizanis et al., 2012) . This complexity is expected given the widespread effect of knocking out Mbnl2 on alternative splicing, including key genes encoding ion channels and synaptic function. For example, adult exon skipping occurs for Cacna1d (Ca v 1.3) that codes for the voltage-gated L-type calcium channel, and Kcnma1 that codes for a large conductance calciumactivated potassium channel (Charizanis et al., 2012) . Additionally, increased inclusion of exon 5 of Grin1, coding for the NMDA receptor type 1 subunit, occurs in Mbnl2 KO mice (Charizanis et al., 2012) , which has been reported to decrease dendritic localization (Pal et al., 2003) .
Persistence of the fetal or misspliced forms of any or a combination of these channels is likely to alter excitability of cortical circuits, as we observed. Furthermore, the developmental splicing defects can be regional as is the fetal pattern. For example, the splicing pattern for Kcnma1 exon 25a differed substantially in the forebrain versus the hindbrain in Mbnl2 KO mice (Charizanis et al., 2012) . Therefore, DM is likely to have differential effects on excitability and synaptic function depending on CNS location.
Of note, there is an alteration in skeletal muscle glucose metabolism in DM1 and DM2 due to increased levels of pyruvate kinase M2 (PKM2) (Gao and Cooper, 2013) . While Mbnl1; Mbnl2 double KO mice show a significant shift towards exon 10 inclusion and increased PKM2 expression, the Mbnl2 KO brain does not (Charizanis et al., 2012) . Therefore, the changes in flavoprotein responses reported here are unlikely to be the result of aberrant PKM2 upregulation and altered glucose metabolism.
Effects of MBNL1 overexpression
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The sequestration of MBNL1 by CUG and CCUG transcripts is likely to play a major role in the splicing abnormalities and the multi-systemic abnormalities in DM (Novak et al., 2000; Kanadia et al., 2003; Yuan et al., 2007; Du et al., 2010) . Therefore, upregulation of MBNL1 is a potential therapeutic strategy for DM. A previous study of transgenic mouse lines (including L14686 mice) demonstrated that overexpression of MBNL1 is well-tolerated in skeletal muscle and MBNL1 overexpression prevents CUG-induced myotonia (Chamberlain and Ranum, 2012) . A recent report also demonstrated that restoring endogenous levels of MBNL proteins decreased missplicing events and restored pathological symptoms in a Drosophila DM1 model (CerroHerreros et al., 2016) . While a promising strategy, the effect of overexpression in the CNS requires investigation. The present results showed that MBNL1 overexpression altered cerebral cortical responsiveness by decreasing the response in the contralateral hemisphere evoked by 10
Hz train stimulation. Given that there was no change in the ipsilateral response, the decreased contralateral response may reflect altered corpus callosum function. As reviewed earlier (see Introduction), white matter and functional connectivity changes in DM1 and DM2 patients, including in the corpus callosum, have been a common finding in anatomical and DTI studies (Fukuda et al., 2005; Ota et al., 2006; Wozniak et al., 2011; Minnerop et al., 2011; Franc et al., 2012; Serra et al., 2014; Serra et al., 2016) . However, we would emphasize that the decreased flavoprotein response in the contralateral hemisphere is not definitive for abnormal corpus callosum function, with additional experiments needed to test other possibilities. For example, MBNL1-OE mice also showed a reduction in the inhibitory-like surround in both hemispheres, consistent with a more general change in synaptic function.
A C C E P T E D M
A N U S C R I P T 38 MBNL1-OE mice showed decreased responses to corpus callosum stimulation that in theory could counteract the increased responsiveness observed in Mbnl2 KO animals. However, overexpression of MBNL1 did not result in a simple reversal of the changes observed in Mbnl2 KO mice. The wild-type center-surround pattern of inhibition was reduced in both mouse models.
Interestingly, there is a modest increase in the expression of MBNL1 in Mbnl2 KO mice (Charizanis et al., 2012) that could account for the decreased inhibitory-like surround observed in the two mouse models. These findings reinforce the complexity introduced with changes in the expression of these important splicing factors. 
A C C E P T E D
